The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19,
Ninety-four per cent of the COVID-19 patients discharged to home health care, achieved statistically significant improvements in symptom burden and functional outcomes and 87 per cent had no adverse events, suggests a new study. The study was conducted by the researchers of the University of Pennsylvania School of Nursing (Penn Nursing)
The study, published in the Annals of Internal Medicine states no data has been available on the outcomes of COVID-19 patients discharged home after hospitalisation and their recovery needs.
The survivors of COVID-19 are a vulnerable population who often have health ramifications from their illness and hospital stay. Upon returning home from acute care, large proportions of survivors experience functional dependencies, pain, dyspnea, and exhaustion.
In the study rich data from more than 1,400, COVID-19 patients admitted to home health care after hospital discharge describes home visit care and recovery extent. The study indicates that increasing referrals to home health care has the potential to provide support and achieve improved recovery for these patients.
"Our findings suggest that acute care providers might carefully consider which COVID-19 survivors would benefit from home health care after hospitalization," writes Kathryn H. Bowles, Ph.D., RN, FAAN, FACMI, Professor of Nursing and van Ameringen Chair in Nursing Excellence at Penn Nursing.
"A decision support tool to identify general hospitalized patients for home health care referral may be helpful." Bowles was the lead investigator of the study.
Type O blood linked to lower risk, taking Vitamin D unlikely to help
A large study adds to evidence that people with type O or Rh−negative blood may be at slightly lower risk from the new coronavirus. Among 225,556 Canadians who were tested for the virus, the risk for a COVID-19 diagnosis was 12% lower and the risk for severe COVID-19 or death was 13% lower in people with blood group O versus those with A, AB, or B, researchers reported on Tuesday in Annals of Internal Medicine.
People in any blood group who were Rh-negative were also somewhat protected, especially if they had O-negative blood. People in these blood type groups may have developed antibodies that can recognize some aspect of the new virus, coauthor Dr. Joel Ray of St. Michael's Hospital in Toronto told Reuters.
"Our next study will specifically look at s uch antibodies, and whether they explain the protective effect," Ray said. Whether or how this information might influence COVID-19 prevention or treatment is still unclear. (bit.ly/2JhQvws)
Vitamin D fails to help in severe COVID-19 cases